Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Aptar Pharma has signed a license agreement with BD to jointly develop and bring a new autoinjector to market.

Aptar Pharma Forms Pact with BD to Develop Novel Autoinjector

Ajay Pazhayattil*, M.Pharm, DBA, Ajay.Pazhayattil@capcium.com, is vice-president, Scientific and Regulatory Affairs at Capcium.

Flexible batch sizes for semi-continuous unit operations, such as tableting and encapsulation, can improve efficiency while maintaining quality.

Determining Minimum Batch Size

David Smith is CMO manager at Glide Pharmaceutical Technologies Ltd.

Alex Lyness is an enterprise fellow at Loughborough University, Healthcare Engineering Group, Centre for Biological Engineering, Wolfson School of Mechanical and Manufacturing Engineering,Loughborough University, Leicestershire, UK.

David Grant is technical lead, new technologies, david.grant@glide-technologies.com.

Scott Constable is principal project co-ordinator, QuotientMetabolism at Quotient Bioresearch (Rushden) Ltd.,Northamptonshire, UK.

Johannah Sharman is regulatory affairs manager at KalvistaPharmaceuticals Ltd.

A study demonstrates the feasibility of a novel solid-dose formulation injection technology to effectively deliver a therapeutic treatment without the aid of a needle.

A Novel Solid-Dose Injection

Agnes Shanley is senior editor of Pharmaceutical Technology.

Analytics and science-based approaches are shedding more light on these complex dosage forms, promising to improve process control and product design.

Topical Formulation: Moving From Art to Science

Robert Strub is director of business development at Gaylord Chemical Company LLC.

The authors review the regulatory changes associated with the use of dimethyl sulfoxide in finished pharmaceutical dosage forms.

Advances in the Regulated Pharmaceutical Use of Dimethyl Sulfoxide USP, Ph.Eur.

The platform combines an expression system with equipment and process controls to enable rapid development and scale-up of robust titers.

Sartorius Stedim Biotech Introduces Fully Integrated Upstream Platform

The merger of Avantor Performance Materials and Nusil Technology positions the company for growth in bioprocessing.

Avantor Performance Materials, Nusil Technology to Merge

GPhA and PBOA commend agreement to reauthorize Generic Drug User Fee Amendments.

Industry Groups Applaud GDUFA Agreement

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Improvements to aseptic manufacturing procedures are long overdue. But how feasible is it for manufacturers to modernize fill lines of legacy products?

Parenteral Advisory: Outmoded Fill/Finish Technology

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Can Competition Block Excessive Pharma Price Hikes? EpiPen Saga Shows It’s Hard